S. 934: FDA Reauthorization Act of 2017
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
The bill’s titles are written by its sponsor.
Overview
- Introduced:
Apr 25, 2017
- Status:
-
Ordered Reported on May 11, 2017
The committees assigned to this bill sent it to the House or Senate as a whole for consideration on May 11, 2017.
- Sponsor:
-
- Text:
-
Read Text »
Last Updated: May 11, 2017
Length: 268 pages - Prognosis:
-
45% chance of being enacted according to Skopos Labs (details)
- See Instead:
-
H.R. 2430 (same title)
Passed House (Senate next) — Jul 12, 2017
History
|
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
|
|
Considered by Senate Committee on Health, Education, Labor, and Pensions
A committee held a hearing or business meeting about the bill.
|
|
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
|
|
Considered by Senate Committee on Health, Education, Labor, and Pensions
A committee held a hearing or business meeting about the bill.
|
|
|
|
Passed Senate (House next)
|
|
|
|
Passed House
|
|
|
|
Signed by the President
|
S. 934 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“S. 934 — 115th Congress: FDA Reauthorization Act of 2017.” www.GovTrack.us. 2017. July 24, 2017 <https://www.govtrack.us/congress/bills/115/s934>
- show another citation format:
- APA
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.